AMY KIEL: Open Payments
NPI 1407555188 · BLUFFTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,633 in 81 payments from 20 companies in 2025. Trend: 2023 $371 · 2024 $1,432 · 2025 $1,633
Food & beverage: $1,633
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $464 |
| ABBVIE INC. | 16 | $282 |
| Amgen Inc. | 11 | $141 |
| Axsome Therapeutics, Inc. | 6 | $107 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $97 |
| Otsuka America Pharmaceutical, Inc. | 5 | $86 |
| PFIZER INC. | 4 | $84 |
| Lilly USA, LLC | 3 | $60 |
| Novo Nordisk Inc | 3 | $59 |
| Exact Sciences Corporation | 2 | $45 |
Products named: FARXIGA, VRAYLAR, BREZTRI, OTEZLA, Auvelity, REXULTI, Kerendia, MOUNJARO.
Industry payments across IN — which companies pay providers there.
